Literature DB >> 6224805

Evidence for cell-mediated immunity and specific suppressor T lymphocyte dysfunction in Graves' disease and diabetes mellitus.

D Topliss, J How, M Lewis, V Row, R Volpé.   

Abstract

Migration inhibition of purified peripheral T lymphocytes in response to pancreatic islet cell antigen or thyroid antigen was used to study cell-mediated immune mechanisms in patients with diabetes mellitus (IDDM) and Graves' disease (GD). In response to islet cell antigen, T lymphocytes of subjects with IDDM for less than 3 yr exhibited migration inhibition, whereas those of normal subjects, noninsulin dependent diabetics, and subjects with IDDM for longer than 3 yr did not. Admixture of T lymphocytes from normal subjects with T lymphocytes from patients with IDDM for less than 3 yr substantially ameliorated the migration inhibition of the IDDM subjects to islet cell antigen. Migration of T lymphocytes from GD subjects was markedly inhibited by thyroid antigen and marginally inhibited by islet cell antigen. Admixture of GD T lymphocytes significantly ameliorated the migration inhibition of IDDM T lymphocytes to islet cell antigen, despite sensitization to thyroid antigen of the GD T lymphocytes. We conclude: 1) sensitization to islet cell antigen in IDDM of recent onset is confirmed; 2) the ability of normal and GD T lymphocytes to ameliorate the migration inhibition of IDDM T lymphocytes strongly suggests correction of deficient suppressor T lymphocyte function; 3) the ability of GD T lymphocytes to ameliorate migration inhibition of IDDM T lymphocytes to islet cell antigen is evidence for an antigen-specific rather than a generalized suppressor T lymphocyte defect in GD; and 4) similarly, the normalization of migration index of GD T lymphocytes in response to thyroid antigen by those IDDM T lymphocytes not sensitized to thyroid antigen is again evidence for an antigen-specific and not a generalized suppressor T lymphocyte defect in IDDM.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6224805     DOI: 10.1210/jcem-57-4-700

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

1.  Remission of Graves' disease with hyperthyroidism by a combination of glucocorticoids and antithyroid drugs.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1991-03       Impact factor: 1.798

2.  Studies on the immunoregulation of thyroid autoantibody production in vitro.

Authors:  P Benveniste; V V Row; R Volpé
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

Review 4.  Autoimmunity and the pathogenesis of glomerulonephritis.

Authors:  D B Oliveira; D K Peters
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 5.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

6.  Study of induction of activation of human peripheral blood mononuclear cells with a non-activating form of anti-CD3 MoAb in autoimmune thyroid disease (AITD).

Authors:  E Resetkova; G Arreaza; N Yoshikawa; T Morita; H Kim; P Carayon; R Volpé
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

7.  Passive transfer of flt-3L-derived dendritic cells delays diabetes development in NOD mice and associates with early production of interleukin (IL)-4 and IL-10 in the spleen of recipient mice.

Authors:  J Morin; B Faideau; M-C Gagnerault; F Lepault; C Boitard; S Boudaly
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

8.  Reduced activation of suppressor T lymphocytes by specific antigens in autoimmune thyroid disease.

Authors:  N Yoshikawa; T Morita; E Resetkova; G Arreanza; P Carayon; R Volpé
Journal:  J Endocrinol Invest       Date:  1993-09       Impact factor: 4.256

9.  The T cell suppressor defect in autoimmune thyroiditis: evidence for a high set 'autoimmunostat'.

Authors:  T F Davies; M Platzer
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

10.  Identification of cells responsible for the suppression of anti-beta-cell cytotoxicity in type I (insulin-dependent) diabetes mellitus.

Authors:  J Krug; B Bierwolf; E Lampeter; H J Verlohren; D Lohmann
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.